-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Jazz Pharmaceuticals plc quarterly/annual Amortization of Intangible Assets history and growth rate from 2010 to 2023.
- Jazz Pharmaceuticals plc Amortization of Intangible Assets for the quarter ending September 30, 2024 was $157M, a 1.66% increase year-over-year.
- Jazz Pharmaceuticals plc Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $620M, a 4.35% increase year-over-year.
- Jazz Pharmaceuticals plc annual Amortization of Intangible Assets for 2023 was $608M, a 1.52% increase from 2022.
- Jazz Pharmaceuticals plc annual Amortization of Intangible Assets for 2022 was $599M, a 14% increase from 2021.
- Jazz Pharmaceuticals plc annual Amortization of Intangible Assets for 2021 was $526M, a 103% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)